2026-01-15 - Analysis Report
**Company Overview:**
Johnson & Johnson is a multinational healthcare company.

**Comparative Return Analysis:**
| Review Ticker (JNJ) | Comparison Ticker (VOO) |
|---------------------|-------------------------|
| Cumulative Return   | Cumulative Return        |
| 60.55%              | 92.89%                   |
| Divergence: -32.34% |                           |

The comparison stock (S&P 500, VOO) has a higher cumulative return compared to the review stock (JNJ) with a divergence of -32.34%.

**Alpha, Beta Analysis:**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 6.0% | 16.8% | 3.0% | 0.7  | 310.9B |
| 2017-2019  | 18.0% | 16.8% | 1.0% | 0.7  | 351.4B |
| 2018-2020  | 19.0% | 16.8% | -2.0% | 0.7  | 379.2B |
| 2019-2021  | 32.0% | 10.7% | -12.0% | 0.6  | 412.2B |
| 2020-2022  | 8.0%  | 13.8% | 10.0% | 0.5  | 425.6B |
| 2021-2023  | -18.0% | 13.8% | -19.0% | 0.3  | 377.6B |
| 2022-2024  | -30.0% | 13.8% | -50.0% | 0.2  | 348.4B |
| 2023-2025  | 30.0%  | 13.8% | -32.0% | 0.1  | 498.6B |

**Recent Stock Price Fluctuation:**
| Metric      | Value    |
|-------------|----------|
| Close (day) | $218.55  |
| Last-Market | $218.55  |
| Change      | $2.29   |
| 5-day SMA   | $210.41 |
| 20-day SMA  | $208.01 |
| 60-day SMA  | $201.08 |

Recent market fluctuations indicate a short-term increase of $2.29.

**RSI and PPO Analysis:**
| Indicator      | Value    |
|----------------|----------|
| RSI           | 73.83    |
| PPO           | 0.31     |
| MRI           | 0.70     |
| Expected Return| -48.40%  |

The RSI is overbought, and the PPO has a low value. The expected return is negative.

**Headlines & Events Analysis:**
* Fund Update: 434,743 JOHNSON & JOHNSON (JNJ) shares added to Canoe Financial LP portfolio - Quiver Quantitative
* Hereâ€™s Why Johnson & Johnson (JNJ) Surged in Q3 - Yahoo Finance
* Is Johnson & Johnson (JNJ) Still Fairly Priced After Its Strong 12-Month Rally? - simplywall.st
* More Upside For JNJ Stock In 2026? - Forbes
* Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court - Reuters
* ORG Partners LLC Has $1.97 Million Holdings in Johnson & Johnson $JNJ - MarketBeat

Latest news and events may indicate some positive factors, but a comprehensive assessment is challenging without further detail.

**Analyst Opinions:**
 Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.16 (~Buy)
- Opinions: 24
- Target Price (avg/high/low): 212.00 / 240.00 / 155.00

Analysts have a moderate buy recommendation for Johnson & Johnson.

**Recent Earnings Analysis:**
| Date     | EPS | Revenue |
|----------|-----|---------|
| 2025-10-22 | 2.14 | 23.99 B$ |
| 2025-07-24 | 2.3   | 23.74 B$ |
| 2025-04-23 | 4.57  | 21.89 B$ |
| 2024-10-23 | 1.12  | 22.47 B$ |
| Duplicate entry, removed. |

Quarterly EPS and revenue have shown some variation.

**Financial Information (Revenue and Profitability)**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $23.99B | 69.56%         |
| 2025-06-30 | $23.74B | 67.87%         |
| 2025-03-31 | $21.89B | 66.40%         |
| 2024-12-31 | $22.52B | 68.35%         |
| 2024-09-30 | $22.47B | 69.01%         |

Revenue and profit margins show some variation.

**Financial Information (Capital and Profitability)**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $79.28B | 6.50% |
| 2025-06-30 | $78.47B | 7.06% |
| 2025-03-31 | $78.11B | 14.08% |
| 2024-12-31 | $71.49B | 4.80% |
| 2024-09-30 | $70.16B | 3.84% |

Equity and ROE have shown variation.

**Comprehensive Analysis:**
- Moderate buy recommendation from analysts
- Recent price fluctuations indicate short-term increases
- Overbought RSI, negative PPO
- Negative expected return of 48.40%
- Variation in quarterly EPS, revenue, profit margins, equity, and ROE

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.